Aurora Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Go Beyond the Preview – Access the Full Value Chain Analysis
This Aurora Value Chain Analysis gives you a clear breakdown of how Aurora creates value through its support and primary activities, useful for research, strategy, investing, or business planning. This page already shows a real preview of the analysis, so you can review the actual content and format before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Aurora's firm infrastructure is built around licensing, compliance, reporting, and quality control, which is critical in Canada's regulated cannabis market and for exports. In fiscal 2025, Aurora reported net revenue of C$343.2 million, showing how much this backbone supports product flow across medical and adult-use channels. Its global setup also matters abroad, where GMP-style quality systems help keep shipments compliant. That control layer is a core part of Aurora's value chain.
Human Resource Management
Aurora's FY2025 net revenue was about C$343 million, so Human Resource Management matters. The company depends on trained cultivators, processors, quality staff, and regulatory teams to keep output steady across licensed sites. Skilled labor also cuts compliance errors and supports its 2025 gross margin of roughly 60%.
Technology Development
In fiscal 2025, Aurora kept technology development focused on research-led product design, especially formulation, extraction, and testing for dried flower, oils, edibles, and concentrates. That work supports product quality and helps the Company tailor cannabinoid profiles, potency, and stability for both medical and adult-use markets. In value chain terms, Aurora turns plant science into higher-value SKUs and a clearer product moat.
Procurement
Procurement at Aurora Value Chain Analysis covers cultivation inputs, packaging, and testing services, so sourcing quality and lead times directly shape unit cost and batch output.
In a regulated market, supplier vetting matters because lot-level testing and compliant packaging can stop shipments if a single part fails specs.
Careful buying also helps Aurora keep production steady, control working capital, and protect margins when input prices or service fees move.
Aurora's FY2025 Backbone: Compliance, People, and Profit
Aurora's support activities in FY2025 centered on compliance, people, R&D, and sourcing. With net revenue of C$343.2 million and gross margin near 60%, these functions helped keep cannabis production licensed, tested, and export-ready. Tight procurement and trained staff also reduced batch risk and supported steady output.
| FY2025 metric | Value |
|---|---|
| Net revenue | C$343.2 million |
| Gross margin | ~60% |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Aurora Cannabis'"s inbound logistics depend on tight receipt, tracking, and storage controls for cultivation inputs and finished goods. In fiscal 2025, Aurora Cannabis reported net revenue of CA$343.3 million, so even small losses in stock handling can hit margins fast. Strong chain-of-custody and inventory checks help cut waste, protect compliance, and keep production on schedule.
Operations
In fiscal 2025, Aurora Cannabis generated about C$343 million in net revenue, showing the scale of its Operations. Aurora cultivates, harvests, processes, and packages cannabis into dried flower, oils, edibles, and concentrates, turning regulated biomass into standardized medical and adult-use products. This controlled production flow supports quality, traceability, and margin control across its supply chain.
Outbound Logistics
Aurora Value Chain Analysis shows outbound logistics as a regulated control point: FY2025 net revenue was C$343.1 million, and finished goods moved through pharmacies, medical clinics, retail stores, and other licensed channels where traceability and compliant paperwork matter as much as delivery speed.
That makes order accuracy, chain-of-custody records, and on-time fulfillment core to service quality, not just transport.
Marketing and Sales
Aurora Value Chain Analysis shows marketing and sales rely on channel partners, brand trust, and product education more than mass consumer ads. In fiscal 2025, Aurora generated C$343.4 million in net revenue, with regulated medical channels helping drive conversion. Shelf access and compliance matter because customers buy in a tightly controlled category, where retailer support and physician trust can outweigh broad promotion.
Service
Aurora's service is mostly after-sale education, dosage guidance, and issue handling through pharmacies, clinics, and other medical channels. This matters because patients who understand how to use the product correctly are more likely to reorder and stay with the brand. Strong service also lowers misuse complaints and keeps medical users confident in their choice.
Aurora Cannabis FY2025: Tight Operations, Thin Margins
Aurora Cannabis' primary activities in fiscal 2025 centered on controlled cultivation, processing, and packaging of medical and adult-use cannabis, supported by strict inventory and compliance checks. Net revenue was C$343.3 million, so small waste or fulfillment errors can quickly hit margin. Outbound delivery through licensed channels and patient support round out the chain.
| Primary activity | FY2025 signal |
|---|---|
| Operations | Net revenue C$343.3 million |
| Outbound logistics | Licensed, traceable channels |
| Service | Patient support and guidance |
Preview Before You Purchase
Aurora Reference Sources
This is the actual Aurora Value Chain Analysis document you'll receive after purchase – no samples, no surprises. The preview below is pulled directly from the full report, so what you see is exactly what you get. Once your order is complete, the full version is unlocked immediately for download.
Frequently Asked Questions
Aurora's value chain is anchored by regulated cultivation, product development, and distribution. The company serves 2 demand pools-medical and adult-use-and offers 4 core product types: dried flower, oils, edibles, and concentrates. That combination lets it create value across multiple channel types while keeping compliance and product consistency central to the model.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.